Charcot-Marie-Tooth Disease - 28 Studies Found

Completed : Follow up and Observation of Charcot Marie Tooth Disease in Families
: Charcot-Marie-Tooth Disease
: 2005-09-07
Completed : Correlation Between Clinical and Electrophysiological Phenotypes in a Population of Patients With Neuropathy Charcot-Marie-Tooth Disease Type 1A
: Charcot-Marie-Tooth Type 1A Neuropathy
: 2012-11-16
Completed : Development and Validation of a Disability Severity Index for CMT
: Charcot Marie Tooth Disease
: 2011-10-17
Completed : Survey of Current Management of Orthopaedic Complications in CMT Patients
: Charcot-Marie-Tooth Disease
: 2013-11-27
: Other: Survey
Completed : High Dose Ascorbic Acid Treatment of CMT1A
: Charcot-Marie-Tooth Disease, Type Ia
: 2007-06-08
:
  • Drug: Ascorbic acid (Vitamin C)

Completed : Genetics of Charcot Marie Tooth (CMT) - Modifiers of CMT1A, New Causes of CMT2
:
  • Charcot-Marie-Tooth Disease, Type Ia (Disorder)
  • HMSN

: 2010-08-09
Active, not recruiting : Phase III Trial Assessing the Efficacy and Safety of PXT3003 in CMT1A Patients (PLEO-CMT)
: Charcot-Marie-Tooth Disease Type 1A
: 2015-09-28
:
  • Drug: PXT3003 dose 1 Liquid or
Completed : Ascorbic Acid Treatment in CMT1A Trial (AATIC)
:
  • Charcot-Marie-Tooth Disease
  • Hereditary Mo
    : 2006-01-03
    :
    • Drug: Placebo Placebo 4 capsul
Completed : Disability Severity Scale (DSI) and Hereditary Motor and Sensory Neuropathy Overall Disability Scale (HMSN-R-ODS)
:
  • Charcot Marie Tooth Disease
  • Inherited Peripheral Neuropathy : 2014-04-02
Completed : Phase II, Randomized, Placebo-controlled Trial in Patients With Charcot-marie-tooth Disease Type 1A
:
  • Charcot-Marie-Tooth Disease
  • Hereditary Neuropathy With Liabilit
    : 2011-07-20
    :
    • Drug: PXT3003 Low dose Liquid,
<<< Previous | Next >>>